Interpace Biosciences Announces U.S. PTO Issuance of Patent No. 11,143,657 Titled: Topographic Genotyping for Determining the Diagnosis, Malignant Potential, and Biologic Behavior of Pancreatic Cysts and Related Conditions PARSIPPANY, NJ, Oct. 28, 2021 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG), a fully integrated commercial company that provides clinically relevant...

Worldwide LiDAR Market expecting 35% growth to cross $10bn by 2025: Global Market Insights, Inc. Selbyville, Delaware, June 13, 2019 (GLOBE NEWSWIRE) -- The environment LiDAR market is expected to register a growth rate of over 32% during the projected time period. The LiDAR technology...